Marex Group Ltd

MRXNASDAQ · USD
72.61USD-3.10 (-4.11%)
3910

Marex Group Ltd (MRX) Expected Move

MRX expected move through Oct 16, 2026 is 10.7%, with 23 days to expiration. The implied range is $64.51 to $80.71, based on the previous trading day's options prices.

Read more

Tracking the MRX expected move helps you see how far Marex Group Ltd's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Marex Group Ltd's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the MRX expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For MRX, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The MRX expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Marex Group Ltd is unlikely to go.

Marex Group plc, a financial services platform provider company, provides liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets in the United Kingdom, the United States, and internationally. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The company offers execution and clearing services in metals, agricultural products, energy and financial futures and options; liquidity and execution services for financial securities through trading desks that cover products, including foreign exchange, equities, fixed income, and others.

It also operates as an agent to trade in OTC energy products using knowledge of the energy sector and relationships with clients for oil, power and gas, and shipping and freight products; and provides market-making services across commodities markets, such as metals, agricultural products, and energy markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across commodity markets comprising agriculture, metals, energy, and currency markets for trading houses, producers and consumers, and banks and distributors. Further, it engages in the structured notes business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, independent asset managers, pension funds, and corporates. Additionally, the company offers technology platforms, including Neon, a trading, risk, and data platform; and Agile, a commodity broking platform. Marex Group plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the MRX expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Marex Group Ltd expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about MRX.

MRX Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Oct 16, 202623$8.1010.7%$80.71$64.51
Nov 20, 202658$13.3017.6%$85.91$59.31
Dec 18, 202686$15.3020.2%$87.91$57.31
Jan 15, 2027114$17.0822.6%$89.69$55.54

As of September 21, 2026

Know What the Market Expects From MRX

Track the MRX expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.

Start your 14-day free trial